These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22039899)

  • 1. Feline mammary tumours and dysplasias conclusions based on personal studies and some suggestions for future research.
    Weijer K
    Vet Q; 1980 Apr; 2(2):69-74. PubMed ID: 22039899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline mammary tumours and dysplasias. Conclusions based on personal studies and some suggestions for future research.
    Weijer K
    Tijdschr Diergeneeskd; 1980 Apr; 105(8):suppl 2:69-74. PubMed ID: 7376173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
    Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
    Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of canine and human breast cancer.
    Owen LN
    Invest Cell Pathol; 1979; 2(4):257-75. PubMed ID: 396282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
    Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
    BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status.
    Martín de las Mulas J; Van Niel M; Millán Y; Ordás J; Blankenstein MA; Van Mil F; Misdorp W
    Res Vet Sci; 2002 Apr; 72(2):153-61. PubMed ID: 12027597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic histopathological and molecular markers in feline mammary neoplasia.
    Hughes K; Dobson JM
    Vet J; 2012 Oct; 194(1):19-26. PubMed ID: 22841451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
    Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
    J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary tumours in the cat: size matters, so early intervention saves lives.
    Morris J
    J Feline Med Surg; 2013 May; 15(5):391-400. PubMed ID: 23603502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
    Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
    Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear cytomorphometry in feline mammary gland epithelial tumours.
    Simeonov R; Simeonova G
    Vet J; 2009 Feb; 179(2):296-300. PubMed ID: 17959399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-cadherin expression in feline mammary tissues.
    Figueira AC; Teodósio AS; Carvalheira J; Lacerda M; de Matos A; Gärtner F
    Vet Med Int; 2012; 2012():687424. PubMed ID: 23091776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of NOS and VEGF in feline mammary tumours and their correlation with angiogenesis.
    Islam MS; Matsumoto M; Hidaka R; Miyoshi N; Yasuda N
    Vet J; 2012 Jun; 192(3):338-44. PubMed ID: 22154426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours.
    Zappulli V; De Cecco S; Trez D; Caliari D; Aresu L; Castagnaro M
    J Comp Pathol; 2012; 147(2-3):161-70. PubMed ID: 22520821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of the feline tumour suppressor reduced expression in immortalized cells (REIC/Dkk-3).
    Ochiai K; Oda H; Shono S; Kato Y; Sugihara S; Nakazawa S; Azakami D; Michishita M; Onozawa E; Bonkobara M; Sako T; Shun-Ai L; Ueki H; Watanabe M; Omi T
    Vet Comp Oncol; 2017 Dec; 15(4):1181-1186. PubMed ID: 27353749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
    Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
    Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of ovariectomy and progestagens in the development of mammary carcinoma in cats].
    Misdorp W; Romijn A; Hart AA
    Tijdschr Diergeneeskd; 1992 Jan; 117(1):2-4. PubMed ID: 1731405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.